Study number 8530-880
Dates
Jun 18 2024-Jul 13 2024
Location
Dallas, Texas
Age
18-55
Gender
Both
Compensation
$6,137
Group
G1
The investigational drug in this research study is being studied for the treatment of inflammatory diseases.
The main purpose of this study is to assess the safety and tolerability of single or multiple doses of the study drug when administered alone or in combination with digoxin, rosuvastatin, or metformin.
Fortrea Dallas, TX is recruiting for:
-Healthy Males and Females, age 18-55
-Body Mass Index between 18-30.5
-Study involves 1 stay of 15 nights & 1 follow-up call
-Compensation up to $6,137 may be provided for time and participation
-Refer a friend to receive $300 per qualified referral
G1:
Check-in: Jun 18
Check-out: Jul 3
Call: Jul 13